Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline [Yahoo! Finance]
Evogene Ltd. - Ordinary Shares (EVGN)
Last evogene ltd. - ordinary shares earnings: 2/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
evogene.com/investor-relations
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Revenue for 2025: Approximately $3.9 million, down from $5.6 million in 2024. Fourth Quarter Revenue 2025: Approximately $0.3 million, down from $1.5 million in the same period last year. Operating Expenses for 2025: Approximately $13.8 million, reduced from $22 million in 2024. Fourth Quarter Operating Expenses 2025: Approximately $3.2 million, down from $4.3 million in the same period of 2024. Net Loss for 2025: Approximately $7.8 million, improved from $18.1 million in 2024. Fourth Quarter Net Loss 2025: Approximately $5.4 million, compared to a net loss of approximately $5,000 in the same period last year. Cash Position as of December 31, 2025: Approximately $13 million. Cost of Revenues for 2025: Approximately $4.1 million, up from $2.4 million in 2024. Fourth Quarter Cost of Revenues 2025: $2.3 million, compared to $0.7 million in the fourth quarter of the previous year. R&D Expenses for 2025: Approximately $8 million
Show less
Read more
Impact Snapshot
Event Time:
EVGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVGN alerts
High impacting Evogene Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
EVGN
News
- Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 [Yahoo! Finance]Yahoo! Finance
- Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026PR Newswire
- Evogene Reports Fourth Quarter and Full Year 2025 Financial ResultsPR Newswire
- Evogene Releases CEO Letter to ShareholdersPR Newswire
- Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results ReleasePR Newswire
EVGN
Sec Filings
- 3/5/26 - Form 6-K
- 2/25/26 - Form 6-K
- 2/19/26 - Form D
- EVGN's page on the SEC website